These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36543254)

  • 21. Pharmacological management of agitation in emergency settings.
    Yildiz A; Sachs GS; Turgay A
    Emerg Med J; 2003 Jul; 20(4):339-46. PubMed ID: 12835344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agitation in the inpatient psychiatric setting: a review of clinical presentation, burden, and treatment.
    Hankin CS; Bronstone A; Koran LM
    J Psychiatr Pract; 2011 May; 17(3):170-85. PubMed ID: 21586995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation).
    Ostinelli EG; Jajawi S; Spyridi S; Sayal K; Jayaram MB
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD008074. PubMed ID: 29308601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A naturalistic study of intramuscular haloperidol versus intramuscular olanzapine for the management of acute agitation.
    MacDonald K; Wilson M; Minassian A; Vilke GM; Becker O; Tallian K; Cobb P; Perez R; Galangue B; Feifel D
    J Clin Psychopharmacol; 2012 Jun; 32(3):317-22. PubMed ID: 22544013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of agitation in mental illness: treatment guidelines and current therapies.
    Marder SR
    J Clin Psychiatry; 2006; 67 Suppl 10():13-21. PubMed ID: 16965191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychopharmacological treatment of aggression in schizophrenic patients.
    Brieden T; Ujeyl M; Naber D
    Pharmacopsychiatry; 2002 May; 35(3):83-9. PubMed ID: 12107851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropharmacology in pediatric brain injury: a review.
    Pangilinan PH; Giacoletti-Argento A; Shellhaas R; Hurvitz EA; Hornyak JE
    PM R; 2010 Dec; 2(12):1127-40. PubMed ID: 21145525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Olanzapine to Treat Agitation in Traumatic Brain Injury: A Series of N-of-One Trials.
    Phyland RK; McKay A; Olver J; Walterfang M; Hopwood M; Ponsford M; Ponsford JL
    J Neurotrauma; 2023 Jan; 40(1-2):33-51. PubMed ID: 35833454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence, treatment and outcomes of agitation among patients with brain injury admitted to acute care units.
    McNett M; Sarver W; Wilczewski P
    Brain Inj; 2012; 26(9):1155-62. PubMed ID: 22642404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting.
    Correll CU; Yu X; Xiang Y; Kane JM; Masand P
    Ann Clin Psychiatry; 2017 May; 29(2):92-107. PubMed ID: 28463343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing agitation during early recovery in adults with traumatic brain injury: An international survey.
    Carrier SL; Hicks AJ; Ponsford J; McKay A
    Ann Phys Rehabil Med; 2021 Sep; 64(5):101532. PubMed ID: 33933690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological management of agitation among individuals with moderate to severe acquired brain injury: A systematic review.
    Mehta S; McIntyre A; Janzen S; Iruthayarajah J; Bateman A; Teasell R
    Brain Inj; 2018; 32(3):287-296. PubMed ID: 29359952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexmedetomidine controls agitation and facilitates reliable, serial neurological examinations in a non-intubated patient with traumatic brain injury.
    Tang JF; Chen PL; Tang EJ; May TA; Stiver SI
    Neurocrit Care; 2011 Aug; 15(1):175-81. PubMed ID: 20198514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic approach to management of agitation associated with dementia.
    Kunik ME; Yudofsky SC; Silver JM; Hales RE
    J Clin Psychiatry; 1994 Feb; 55 Suppl():13-7. PubMed ID: 7915710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A naturalistic evaluation of intramuscular ziprasidone versus intramuscular olanzapine for the management of acute agitation and aggression in children and adolescents.
    Khan SS; Mican LM
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):671-7. PubMed ID: 17201611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited evidence for the effectiveness of p.r.n. Medications among psychiatric inpatients.
    Srivastava A
    J Psychiatr Pract; 2009 May; 15(3):193-201. PubMed ID: 19461392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis.
    Gobbi G; Gaudreau PO; Leblanc N
    J Clin Psychopharmacol; 2006 Oct; 26(5):467-73. PubMed ID: 16974186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacological treatment of post-traumatic behavioural disorders].
    Richard I; Perrouin-Verbe B; Rome J; Bernat C; Mathé JF
    Ann Readapt Med Phys; 2003 Feb; 46(1):49-57. PubMed ID: 12657482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments.
    Liu CS; Ruthirakuhan M; Chau SA; Herrmann N; Carvalho AF; Lanctôt KL
    Curr Alzheimer Res; 2016; 13(10):1134-44. PubMed ID: 27137221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescribing Patterns of Amantadine During Pediatric Inpatient Rehabilitation After Traumatic Brain Injury: A Multicentered Retrospective Review From the Pediatric Brain Injury Consortium.
    McLaughlin MJ; Caliendo E; Lowder R; Watson WD; Kurowski B; Baum KT; Blackwell LS; Koterba CH; Hoskinson KR; Tlustos SJ; Zimmerman KO; Shah SA; Suskauer SJ
    J Head Trauma Rehabil; 2022 Jul-Aug 01; 37(4):240-248. PubMed ID: 34320554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.